ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
about
The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias.Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.Novel targets for ATM-deficient malignancies.Functional proteomic insights in B-cell chronic lymphocytic leukemia.EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients.Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.The impact of SF3B1 mutations in CLL on the DNA-damage response.Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway.Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach
P2860
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
P248
Q33409459-D63A7B45-972A-4921-91AB-CAB0C0215D71Q35149661-C47804A0-2EEE-4BD7-A880-FDAAF94BDF8DQ35832062-0239AD00-2CDA-455A-A5E3-846989968BECQ35859176-A1E07AFD-07B9-41D2-8701-D0B657F3EDB5Q36022313-C9163882-6C9D-449A-9263-1F9BCC18368AQ37325003-9C4CB72A-FA23-4077-9559-D041DF0E5D2AQ38177771-E2DEAE4E-CEAC-45B5-8459-388A74975E26Q38866642-2262D3CF-031E-4AE4-A36B-FD12C29E5B4CQ39048554-BDF29AC9-5759-455E-947D-E100EEF99059Q40455172-86DB5815-8B3D-4D85-9301-60226C25CD6FQ40972934-0A9BFF67-B303-40BB-957C-B68B1DD1099AQ42399864-8D74D0C7-1CDE-4798-ADE2-60BF61F32EC1Q43931229-228D9E77-FC6D-4F06-A7E7-D1CD4E3B31E4Q44290485-41AF9E55-3384-4738-9E7A-06330B681F27Q54191292-480A550B-3056-4BCF-AED6-1F42C55EAD1AQ58041691-B72469D6-24B7-4B6B-B513-2C02A5AC021B
P2860
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ATM mutations uniformly lead t ...... tional test using doxorubicin.
@en
type
label
ATM mutations uniformly lead t ...... tional test using doxorubicin.
@en
prefLabel
ATM mutations uniformly lead t ...... tional test using doxorubicin.
@en
P2093
P2860
P1433
P1476
ATM mutations uniformly lead t ...... ctional test using doxorubicin
@en
P2093
Blanka Kubesova
David Potesil
Jana Kminkova
Jana Smardova
Jana Zemanova
Jiri Mayer
Jitka Malcikova
Ludmila Sebejova
Marek Mraz
Martin Trbusek
P2860
P304
P356
10.3324/HAEMATOL.2012.081620
P577
2013-04-12T00:00:00Z